Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly for targeting protein kinases involved in inflammatory diseases and cancer. Its structure allows selective modification to enhance binding affinity and metabolic stability in drug candidates. Also explored in the development of central nervous system agents due to its ability to cross the blood-brain barrier. Commonly employed in structure-activity relationship (SAR) studies to optimize potency and selectivity in novel therapeutic compounds.